Literature DB >> 24142841

Neurological Complications in Controlled HIV Infection.

Kate M Crossley1, Bruce J Brew.   

Abstract

In recent years, there have been great advances in therapies for human immunodeficiency virus (HIV) that have allowed suppression of the virus and its effects on the body. Despite this progress, neurological complications persist in HIV-infected individuals. In this review we consider the possible ways that HIV might cause neurotoxicity and neuroinflammation. We discuss the spectrum of neurological disorders caused by HIV and its treatment, with a particular focus on both HIV-associated neurocognitive disorders and peripheral neuropathies. Since there has been a shift to HIV being a chronic illness, we also review the increasing prevalence of cerebrovascular disease and neurodegenerative disorders.

Entities:  

Year:  2013        PMID: 24142841     DOI: 10.1007/s11908-013-0375-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  46 in total

Review 1.  Neurocognitive dysfunction in the highly active antiretroviral therapy era.

Authors:  Nomvuyo Z Mothobi; Bruce J Brew
Journal:  Curr Opin Infect Dis       Date:  2012-02       Impact factor: 4.915

Review 2.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

Review 3.  Manifestations of HIV infection in the peripheral nervous system.

Authors:  Chad M Centner; Kathleen J Bateman; Jeannine M Heckmann
Journal:  Lancet Neurol       Date:  2013-03       Impact factor: 44.182

Review 4.  Neurological complications in HIV.

Authors:  Celia Hogan; Ed Wilkins
Journal:  Clin Med (Lond)       Date:  2011-12       Impact factor: 2.659

5.  CSF amyloid beta42 and tau levels correlate with AIDS dementia complex.

Authors:  B J Brew; L Pemberton; K Blennow; A Wallin; L Hagberg
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

Review 6.  Current understanding of HIV-associated neurocognitive disorders pathogenesis.

Authors:  Patrick Gannon; Muhammad Z Khan; Dennis L Kolson
Journal:  Curr Opin Neurol       Date:  2011-06       Impact factor: 5.710

Review 7.  Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy.

Authors:  Belinda Cruse; Lucette A Cysique; Romesh Markus; Bruce J Brew
Journal:  J Neurovirol       Date:  2012-04-14       Impact factor: 2.643

8.  Axonal excitability in viral polyneuropathy and nucleoside neuropathy in HIV patients.

Authors:  Karl Ng; Kishore Kumar; Bruce Brew; David Burke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-16       Impact factor: 10.154

9.  Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease.

Authors:  L Garvey; A Winston; J Walsh; F Post; K Porter; B Gazzard; M Fisher; C Leen; D Pillay; T Hill; M Johnson; R Gilson; J Anderson; P Easterbrook; L Bansi; C Orkin; J Ainsworth; A Palfreeman; M Gompels; A N Phillips; C A Sabin
Journal:  Neurology       Date:  2011-02-22       Impact factor: 9.910

Review 10.  Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis.

Authors:  Laura B Jaeger; Avindra Nath
Journal:  Dis Model Mech       Date:  2012-03-22       Impact factor: 5.758

View more
  1 in total

1.  HIV-1 Nef induces CCL5 production in astrocytes through p38-MAPK and PI3K/Akt pathway and utilizes NF-kB, CEBP and AP-1 transcription factors.

Authors:  Xun Liu; Ankit Shah; Mohitkumar R Gangwani; Peter S Silverstein; Mingui Fu; Anil Kumar
Journal:  Sci Rep       Date:  2014-03-24       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.